Home » Topics » Regulatory » Patents

Patents
RSS

TpoR agonists identified by Shanghai Hengrui for the treatment of thrombocytopenia

Sep. 15, 2009

Novel oncolytic PI3-kinase inhibitors claimed by Genentech and Roche

Sep. 15, 2009

Generics describes tegaserod salts for the treatment of irritable bowel syndrome

Sep. 15, 2009

NPY Y5 antagonists in development at GSK for the treatment of eating disorders

Sep. 14, 2009

Chinese scientists describe a novel series of anti-HIV agents

Sep. 14, 2009

BACE1 inhibitors for the treatment of cognitive disorders discovered by Janssen

Sep. 14, 2009

AstraZeneca discloses Janus kinase inhibitors for the treatment of cancer

Sep. 14, 2009

Novel oncolytic compounds claimed by Korean scientists

Sep. 14, 2009

Medivation Technologies presents novel compounds for cognitive and psychotic disorders

Sep. 10, 2009

PDE4 inhibitors and mAChRs antagonists disclosed by GSK for respiratory diseases

Sep. 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...